Anti-FB protease therapeutics (Catalyst Biosciences)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAnti-FB protease therapeutics (Catalyst Biosciences)
Drug Alias Namechronic protease therapeutics (Catalyst Biosciences)
ClassificationBiologics
Mechanisms of ActionComplement factor B inhibitors
TargetsComplement factor B
Therapy Area/IndicationsHemolytic-Uremic SyndromeLupus Nephritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCatalyst Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCatalyst Biosciences Inc
Active IndicationsN/A
Inactive IndicationsHemolytic-Uremic SyndromeLupus Nephritis

Other Information

ATC CodeN/A
Related LinksN/A